| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |